A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A pediatric oncology group study

This publication has 14 references indexed in Scilit:

• Pediatric Oncology Group Utilization of Immunologic Markers in the Designation of Acute Lymphocytic Leukemia Subgroups: Influence on Treatment Response^a
  Annals of the New York Academy of Sciences, 1984
• Pre-B cell leukemia responds poorly to treatment: a pediatric oncology group study
  Blood, 1984
• Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in Children
  New England Journal of Medicine, 1983
• Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma
  Cancer, 1982
• Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study
  Blood, 1982
• Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation
  Journal of Chronic Diseases, 1981
• Effective therapy for Burkitt's lymphoma: High-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy
  Cancer Chemotherapy and Pharmacology, 1979
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977
• FACTORS THAT INFLUENCE HAEMATOLOGICAL REMISSION DURATION IN ACUTE LYMPHOCYTIC LEUKAEMIA
  British Journal of Haematology, 1976
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958